Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (iv) All inpatient clients, ratio of males to females by country and primary drug

Country		Opioids	Cocaine	Stimulants	Hypnotics and sedatives	Hallucinogens	Volatile substances	Cannabis	Other drugs	Gender and drug known
Belgium	(1)	4.4	4.7	3.0	7.3			10.1		1291
Bulgaria	(2)	7.6								502
Czech Republic	(3)	2.3	1.0	1.6	2.5			4.5	0.5	2157
Denmark		3.0	2.8	2.0	0.7			3.4	11.0	301
Germany	(4)	4.2	10.6	3.9	0.6		1.5	6.6	3.3	5633
Estonia										0.0
Ireland		2.5	5.0	4.8	0.9		2.0	4.4	0.0	1071
Greece		7.0	5.6		2.1			3.6		1931
Spain										0.0
France		3.9	9.0	3.0	13.0	0.5		5.1	1.0	381
Italy										0.0
Cyprus		7.3	16.0					1.0		83
Latvia	(5)	3.0		3.3	2.7			17.6	1.1	725
Lithuania										0
Luxembourg		5.0	1.4					0.0		87
Hungary		4.3	3.0	24.0	1.0		2.0	3.0	2.3	217.0
Malta										0.0
Netherlands										0.0
Austria		2.7	8.1	2.0	1.2	3.0		10.8		1165
Poland										0.0
Portugal										0.0
Romania		7.5	3.0	7.0	0.4		9.0	11.0	1.1	1522
Slovenia										0.0
Slovakia		3.6	0.5	4.4	0.8		6.3	13.1		658
Finland		2.4	3.0	2.1	2.0			3.8		873
Sweden		2.1	7.8	1.9	1.6	3.0	1.5	4.6	3.7	2467
United Kingdom		2.6	2.3	2.3	1.4	2.0	4.0	4.3	3.7	4219
Croatia	(6)	3.9	2.7	2.8	0.8			6.6	2.7	1057
Turkey		15.3	6.2	4.1	4.3		47.5	36.4	13.0	2141
Norway										0.0
Total		3.8	4.2	2.2	1.1	7.5	14.7	7.0	2.6	3.5
Total base		16337	1949	3665	1367	51	329	3654	1129	28481

Notes:

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) Last available data refer to 2005 and to outpatient centres and low-threshold agencies (aggregated data). Brussels Capital Region is not covered. For Hallucinogens 6 male cases have been reported 

 (2) For Stimulants 6 males have been reported. 

 (3) For Volatile substances 17 males have been reported 

 (4) For Hallucinogens 11 males have been reported 

 (5) For Volatile substances 19 males have been reported 

 (6) For Hallucinogens 6 males have been reported 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — TDI — inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)